Global ECMO Devices Supply, Demand and Key Producers, 2026-2032
Description
The global ECMO Devices market size is expected to reach $ 346 million by 2032, rising at a market growth of 3.6% CAGR during the forecast period (2026-2032).
Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.
Market Drivers:
Rising Incidence of Cardiopulmonary Disorders:
Increasing cases of respiratory and cardiac diseases, such as chronic obstructive pulmonary disease (COPD), heart failure, and acute respiratory distress syndrome (ARDS), drive demand for ECMO devices. These devices are essential for patients whose heart and lungs need support, especially during severe cases or surgeries.
Advancements in ECMO Technology:
Innovations like portable ECMO devices, improved oxygenators, and better control systems have enhanced the safety and effectiveness of ECMO therapy, expanding its applications and encouraging adoption in a broader range of healthcare settings.
Increasing Use in COVID-19 and Critical Care:
The COVID-19 pandemic highlighted the need for advanced respiratory support for patients with severe respiratory failure. ECMO became a critical intervention in some severe cases, increasing awareness and demand for these devices.
Growing Use in Pediatric and Neonatal Care:
ECMO devices are increasingly being used in neonatal and pediatric ICUs to support infants with congenital heart disease or respiratory failure, expanding the market across different age groups.
Rising Number of Specialized Healthcare Facilities:
The increase in specialized healthcare centers, especially in developed economies, has made ECMO therapy more accessible, as these devices are often only available in well-equipped, high-acuity centers.
Market Challenges:
High Cost of ECMO Therapy and Devices:
ECMO treatment and the devices themselves are expensive, making them less accessible, particularly in low-income regions or countries with limited healthcare budgets. This limits adoption to only the most severe cases and to hospitals that can afford the technology.
Requirement of Skilled Professionals:
ECMO procedures are complex and require specialized training for operation and monitoring. A shortage of trained ECMO technicians and specialists poses a significant challenge, as improper handling can lead to serious complications.
Risk of Complications:
ECMO therapy has associated risks, such as bleeding, infection, and clotting issues, which can deter its usage in certain patients or situations. These risks require close monitoring and increase the need for experienced healthcare staff.
Strict Regulatory Standards:
ECMO devices are subject to stringent regulations by authorities like the FDA, which requires extensive testing for safety and efficacy. These regulatory hurdles can delay product approvals and increase costs for manufacturers.
Limited Awareness and Accessibility in Developing Regions:
In emerging markets, awareness about ECMO technology and access to it are limited due to a lack of trained professionals and high treatment costs. This restricts the market potential in regions where the healthcare infrastructure is less developed.
Global players of ECMO Devices include Medtronic, Getinge (Maquet), LivaNova (Sorin), Terumo and Fresenius Medical Care. Medtronic is the largest player, with a share about 34%. North America is the largest market, with a share about 40%, followed by Europe and China. In terms of product, VV (Veno-Venous) ECMO is the largest segment, with a share over 70%. In terms of application, Adult is the largest market, with a share about 80%.
This report studies the global ECMO Devices production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for ECMO Devices and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of ECMO Devices that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global ECMO Devices total production and demand, 2021-2032, (Units)
Global ECMO Devices total production value, 2021-2032, (USD Million)
Global ECMO Devices production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global ECMO Devices consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: ECMO Devices domestic production, consumption, key domestic manufacturers and share
Global ECMO Devices production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global ECMO Devices production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global ECMO Devices production by End Users, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global ECMO Devices market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Getinge (Maquet), LivaNova (Sorin), Terumo, Fresenius Medical Care, Chinabridge(Shenzhen) Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World ECMO Devices market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Units) by manufacturer, by Type, and by End Users. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global ECMO Devices Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global ECMO Devices Market, Segmentation by Type:
VA (Veno-Arterial) ECMO
VV (Veno-Venous) ECMO
Global ECMO Devices Market, Segmentation by End Users:
Adult
Neonatal
Pediatric
Companies Profiled:
Medtronic
Getinge (Maquet)
LivaNova (Sorin)
Terumo
Fresenius Medical Care
Chinabridge(Shenzhen) Medical
Key Questions Answered:
1. How big is the global ECMO Devices market?
2. What is the demand of the global ECMO Devices market?
3. What is the year over year growth of the global ECMO Devices market?
4. What is the production and production value of the global ECMO Devices market?
5. Who are the key producers in the global ECMO Devices market?
6. What are the growth factors driving the market demand?
Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.
Market Drivers:
Rising Incidence of Cardiopulmonary Disorders:
Increasing cases of respiratory and cardiac diseases, such as chronic obstructive pulmonary disease (COPD), heart failure, and acute respiratory distress syndrome (ARDS), drive demand for ECMO devices. These devices are essential for patients whose heart and lungs need support, especially during severe cases or surgeries.
Advancements in ECMO Technology:
Innovations like portable ECMO devices, improved oxygenators, and better control systems have enhanced the safety and effectiveness of ECMO therapy, expanding its applications and encouraging adoption in a broader range of healthcare settings.
Increasing Use in COVID-19 and Critical Care:
The COVID-19 pandemic highlighted the need for advanced respiratory support for patients with severe respiratory failure. ECMO became a critical intervention in some severe cases, increasing awareness and demand for these devices.
Growing Use in Pediatric and Neonatal Care:
ECMO devices are increasingly being used in neonatal and pediatric ICUs to support infants with congenital heart disease or respiratory failure, expanding the market across different age groups.
Rising Number of Specialized Healthcare Facilities:
The increase in specialized healthcare centers, especially in developed economies, has made ECMO therapy more accessible, as these devices are often only available in well-equipped, high-acuity centers.
Market Challenges:
High Cost of ECMO Therapy and Devices:
ECMO treatment and the devices themselves are expensive, making them less accessible, particularly in low-income regions or countries with limited healthcare budgets. This limits adoption to only the most severe cases and to hospitals that can afford the technology.
Requirement of Skilled Professionals:
ECMO procedures are complex and require specialized training for operation and monitoring. A shortage of trained ECMO technicians and specialists poses a significant challenge, as improper handling can lead to serious complications.
Risk of Complications:
ECMO therapy has associated risks, such as bleeding, infection, and clotting issues, which can deter its usage in certain patients or situations. These risks require close monitoring and increase the need for experienced healthcare staff.
Strict Regulatory Standards:
ECMO devices are subject to stringent regulations by authorities like the FDA, which requires extensive testing for safety and efficacy. These regulatory hurdles can delay product approvals and increase costs for manufacturers.
Limited Awareness and Accessibility in Developing Regions:
In emerging markets, awareness about ECMO technology and access to it are limited due to a lack of trained professionals and high treatment costs. This restricts the market potential in regions where the healthcare infrastructure is less developed.
Global players of ECMO Devices include Medtronic, Getinge (Maquet), LivaNova (Sorin), Terumo and Fresenius Medical Care. Medtronic is the largest player, with a share about 34%. North America is the largest market, with a share about 40%, followed by Europe and China. In terms of product, VV (Veno-Venous) ECMO is the largest segment, with a share over 70%. In terms of application, Adult is the largest market, with a share about 80%.
This report studies the global ECMO Devices production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for ECMO Devices and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of ECMO Devices that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global ECMO Devices total production and demand, 2021-2032, (Units)
Global ECMO Devices total production value, 2021-2032, (USD Million)
Global ECMO Devices production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global ECMO Devices consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: ECMO Devices domestic production, consumption, key domestic manufacturers and share
Global ECMO Devices production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global ECMO Devices production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global ECMO Devices production by End Users, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global ECMO Devices market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Getinge (Maquet), LivaNova (Sorin), Terumo, Fresenius Medical Care, Chinabridge(Shenzhen) Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World ECMO Devices market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Units) by manufacturer, by Type, and by End Users. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global ECMO Devices Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global ECMO Devices Market, Segmentation by Type:
VA (Veno-Arterial) ECMO
VV (Veno-Venous) ECMO
Global ECMO Devices Market, Segmentation by End Users:
Adult
Neonatal
Pediatric
Companies Profiled:
Medtronic
Getinge (Maquet)
LivaNova (Sorin)
Terumo
Fresenius Medical Care
Chinabridge(Shenzhen) Medical
Key Questions Answered:
1. How big is the global ECMO Devices market?
2. What is the demand of the global ECMO Devices market?
3. What is the year over year growth of the global ECMO Devices market?
4. What is the production and production value of the global ECMO Devices market?
5. Who are the key producers in the global ECMO Devices market?
6. What are the growth factors driving the market demand?
Table of Contents
96 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Manufacturers Competitive Analysis
- 4 United States VS China VS Rest of the World
- 5 Market Analysis by Type
- 6 Market Analysis by End Users
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
